Candel Therapeutics, Inc.CADLNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank67
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.61
↑ 35% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-0.95
Historical baseline
PeriodValueYoY Change
TTM-0.61+64.8%
2024-1.74-32.8%
2023-1.31-1217.9%
2022-0.10+92.1%
2021-1.26-6.8%
2020-1.18-174.4%
2019-0.43-